The University of Chicago Header Logo

Connection

Yusuke Nakamura to Drug Design

Back to Details
This is a "connection" page, showing publications Yusuke Nakamura has written about Drug Design.
Yusuke Nakamura
Connection Strength
0.046
Drug Design
  1. Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer. Oncotarget. 2012 Dec; 3(12):1629-40.
    View in: PubMed
    Score: 0.027
  2. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer. Clin Cancer Res. 2007 Nov 15; 13(22 Pt 1):6624-31.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.